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Abstract Cardiac multimodality (hybrid) imaging can be
obtained from a variety of techniques, such as nuclear medi-
cine with single photon emission computed tomography
(SPECT) and positron emission tomography (PET), or radi-
ology with multislice computed tomography (CT), magnetic
resonance (MR) and echography. They are typically combined
in a side-by-side or fusion mode in order to provide functional
and morphological data to better characterise coronary artery
disease, with more proven efficacy than when used separately.
The gained information is then used to guide revascularisation
procedures. We present an up-to-date comprehensive over-
view of multimodality imaging already in clinical use, as well
as a combination of techniques with promising or developing
applications.
Keywords PET/CT . SPECT/CT . PET/MR .Myocardial
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Introduction
“Ischemic cardiomyopathy” is defined as a weakness in the
heart muscle due to inadequate oxygen delivery to the
myocardium, with coronary artery disease (CAD) being the
most common cause [1]. Thus, ischemic cardiomyopathy re-
fers to a mix of ischemia and infarction, which is not currently
supported in the AHA or ESC classification schemes [1]. The
exact mechanism of ischemic cardiomyopathy is still under
investigation and hibernating myocardium is presumed to be a
complex adjustment to repetitive ischemia-reperfusion [2].
Multimodality cardiovascular imaging involves combi-
nation of at least two out the four existing cardiovascular
imaging (nuclear cardiology with single photon emission
computed tomography [SPECT] and positron emission to-
mography [PET], computed tomography coronary angiogra-
phy [CTCA] and magnetic resonance imaging [MR]; for
comprehensive reviews, see [3, 4]), the most frequent being
PET/CT and SPECT/CT. There have been appropriate use
criteria (AUC) published on the appropriateness of each tech-
nique for a given indication [5]. However, such criteria do not
include hybrid-imaging technology yet. To adequately inter-
pret such hybrid imaging, specialised cardiovascular imaging
training programs have also been developed to include a 1- to
2-year multimodality component, and certification of physi-
cians is now in discussion by professional bodies [6].
However, hybrid (fusion) imaging allows gaining impor-
tant and complementary information and constitutes an op-
portunity for the future of cardiovascular imaging [7•]. Indeed,
within the last decade, there has been a tremendous growth in
cardiovascular imaging and there is a need to define imaging
pathways for different clinical scenarios to identify cost-
effective and diagnostically accurate algorithms [8]. In the
developing “Image-Guided Therapy” paradigm, intervention-
al cardiologists will need to gain information from non-
invasive cardiovascular imagers to guide revascularisation
efforts [9]. The integration of coronary anatomy and myocar-
dial perfusion imaging has been recognised to offer improved
diagnostic and prognostic information that could translate into
improved patient care [10].
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We will present an overview of the different combinations
of hybrid imaging modalities to characterise ischemic cardio-
myopathy, whether they are used frequently or are still in early
development (Table 1).
SPECT-Based Hybrid Techniques
SPECT/CTCA
The addition of CT to SPECT allows attenuation correction
and a better assessment of SPECT myocardial perfusion [11],
although its use is not widespread and many centres continue
to use simpler techniques such as prone imaging [12]. This
combination of CT for attenuation correction is also not
understood as hybrid imaging per se. In this overview, hybrid
imaging is more thought of combining CTCA to SPECT in
terms of diagnostic and prognostic value in ischemic cardio-
myopathy. For a detailed, recent review on hybrid SPECT/CT
imaging, we can recommend the reader to the latest work by
Gaemperli et al. [13••]. These authors performed initial clin-
ical testing [14] and sensed very early the potential for hybrid
imaging in cardiology [15].
Added Value of Calcium Scoring
The use of a CT in combination with SPECT or PET allows
assessing coronary artery calcium (CAC), which is a repro-
ducible, inexpensive method to determine prognostic cardio-
vascular events rate [16, 17]. In combination with SPECT/CT,
CAC was shown to unmask single or multiple vessel disease
when highly elevated (CAC >1000) in patients with normal
SPECTMPI [18]. In addition, it was shown to be a strong risk
predictor of postoperative noncardiac surgery major cardio-
vascular events [19]. Even though limited evidence as to
whether such imaging biomarkers lead to improved outcome,
identification of coronary atherosclerosis by CAC scanning
does lead to lifestyle changes and the intensification of med-
ical therapies.
Added Value of Computed Tomography Coronary
Angiography (CTCA)
It is known that CTA alone performs poorly to predict myo-
cardial ischemia with a low positive predictive value as com-
pared with SPECT (29–58%) [20–24]. However, the negative
predictive value of a CTA examination is excellent (88–
100 %) especially in a low risk population and practically
excludes obstructive CAD and the need for further investiga-
tion. Thus, combining both SPECT with CTCA offers very
good accuracy performances to detect hemodynamically sig-
nificant coronary artery lesions [20, 25] (Fig. 1).
In an original study, Schaap et al. found that hybrid imag-
ing with SPECT/CTCA led to similar treatment decision on
revascularisation of coronary lesions by PCI or CABG in 107
patients with stable angina pectoris as SPECT followed by
invasive coronary angiography [26]. In a similar study, Dong
et al. found that SPECT/CTCA accurately detected function-
ally relevant coronary artery lesion as compared to ICA in 78
patients undergoing both examination within 1 month [27].
They concluded that SPECT/CTA could act as a potential
gatekeeper for revascularisation. Of note, they observed that
37 % of the vascularised vessels were not associated with
ischemia on myocardial perfusion imaging. Finally,
Koukouradis and co-workers observed that SPECT/CTCA
fusion imaging considerably altered the clinical decision for
referral to further investigation [28]. Indeed, in 25 patients, 17
(68 %) were classified as having hemodynamically significant
lesions based on SPECT imaging; when using SPECT/CTCA
hybrid fusion, only six (24 %) were classified as having
hemodynamically significant lesions.
Added Diagnostic Value of Hybrid Fusion Imaging
as Compared to Side-by-side Analysis
Several studies have been comparing the added diagnostic
value of hybrid fusion imaging as compared to separate
side-by-side reading and found that it could confirm or ex-
clude significant stenotic lesions in about 35 and 25 % [14],
Table 1 Cardiac imaging modalities that can be combined in hybrid fashion, with their publication frequency in the literature (●●● = frequently; ●● =
occasional; ● = in development; ○ = experimental; Ø = no application described)
– SPECT PET MR CTP ICA CTCA
SPECT (single photon emission computed tomography) – Ø SPECT/MR (○) Ø Ø SPECT/CTCA (●●●)
PET (positron emission tomography) – PET/MR (●) Ø PET/ICA (○) PET/CTCA (●●)
MR (magnetic resonance) gadolinium injection – Ø Ø MR/CTCA (●)
CTP (computed tomography perfusion) adenosine – Ø CTP/CTCA* (●)
ICA (invasive coronary angiography) – ICA/CTCA (○)
CTCA (computed tomography coronary angiography) –
*Not corresponding exactly to the definition of hybrid imaging as both perfusion and anatomical imaging originates from CT
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respectively, modify the initial diagnosis in 28 % of the cases
[29] and increase diagnostic performances of finding the
stenotic coronary artery in the LCX and RCA territories
[30]. An example of SPECT/CTCA fusion is given in Fig. 2.
Added Prognostic Value of Hybrid Fusion Iimaging
An important demonstration of the added prognostic value of
hybrid imaging and its impact on patient management was
performed by Pazhenkottil et al. [31]. In their follow-up study
of 324 consecutive patients with known or suspected CAD
referred for a 1-day stress/rest SPECT and a CTCA, they
found valuable risk stratification information in hybrid imag-
ing with an independent prediction of major acute coronary
events (such as cardiac death, myocardial infarct, unstable
ang ina requ i r ing hosp i t a l i s a t ion and coronary
revascularisations). To this aim, they stratified patients accord-
ing to the matching of both SPECT and CTCA into three
groups: (1) reversible stress defect on SPECT and lesion on
CTCA; (2) reversible stress defect on SPECT or a lesion on
CTCA; and (3) normal SPECT and CTCA. They concluded
that patients with matched hybrid defects were at higher risk
than if findings were unmatched or normal (Fig. 3).
Perspective
The exact sequence in which to perform the SPECT and
CTCA studies remains undetermined. However, a consensus
seems to emerge in the literature with the personal likelihood
of CAD being a fair option to orient this choice [32•]. In fact,
patients with low pre-test likelihood of CAD could first un-
dergo CTCA and stop further investigation if normal, thanks
to the very high NPVof CTCA. If clearly positive or doubtful
for a coronary lesion, the patient should undergo a SPECT (or
PET) determination of stenosis significance on the myocardial
blood flow. If the pre-test probability of CAD is higher or if
Sensibility Sensitivity PPV NPV
Rispler  2007 96% 95% 77% 99%
Sato 2010 94% 92% 85% 97%
Namdar 2005 90% 98% 82% 99%
Groves 2009 88% 100% 97% 99%
Kajander 2010 93% 99% 96% 99%
0%
20% 
40% 
60% 
80% 
100%
Added value of SPECT/CTCA or PET/CTCA
Fig. 1 Diagnostic added value of SPECT/CTCA (Rispler et al. [20], Sato
et al. 2010 [25]) and PET/CTCA (Namdar et al. [42], Groves et al. [43],
and Kajander et al. [44]) as compared to invasive coronary angiography
on a vessel-based analysis. Abbreviations: PPV=positive predictive like-
lihood; NPV=negative predictive likelihood
Fig. 2 Example of hybrid SPECT/CTA under adenosine pharmacolog-
ical stress in a 58-year male patient with two coronary stents (one
implanted in the proximal left anterior descending [LAD] and one in
the first diagonal branch) (a) A myocardial perfusion imaging was
requested for investigating the start of angor similar as described before
stent implantation. The CTCA did not show any intra-stent stenosis, but
failed to visualize a small branch from the LAD which was recovered by
the stent mesh and which was not visible anymore on CTCA, responsible
for the symptomatic ischemia with a stress-induced perfusion defect
(summed stress score=10; summed rest score=4; summed difference
score=6). There was unfortunately no possibility to revascularize this
small branch and, consequently, maximal risk factor reduction and phys-
ical activity training were recommended. (b) After 9 months, myocardial
perfusion imaging was repeated and fused with the same CTCA and
regained normal perfusion at stress and rest, without ischemia and scar
NORMAL
SPECT & CTCA 
MISMATCHED
Abnormal SPECT or
CTCA
MATCHED       
Abnormal SPECT & 
CTCA
MACE 2.2% 7.8% 21.0% 
Death or MI 1.3% 2.8% 6.0%
0.0%
5.0%
10.0% 
15.0% 
20.0% 
Annualized rate of MACE or death/MI 
Fig. 3 Annualized event rate of major acute coronary event (MACE:
cardiac death, myocardial infarct, unstable angina requiring hospitaliza-
tion and coronary revascularizations) and hard events (myocardial infarct
[MI]/cardiac death) according to the outcome of the individual SPECT
and CTCA studies stratified according to the yielded results and their
agreement (matched vs. unmatched) (data from the study by Pazhenkottil
et al. [31])
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the patient has known CAD, a SPECT would be performed
first and if revascularisation either by PCI or CABG would be
considered in the presence of multivessel disease, a CTCA
would be performed.
SPECT/MR
There might be interest in combining hybrid imaging from
SPECT and MR, although no commercial SPECT/MR ma-
chine is sold today. Indeed, an interesting study found that in
case of doubtful viability by MR, performing a gated-SPECT
could detect viability or ischemia in up to 31 % of the seg-
ments with 50–75 % late-gadolinium enhancement [33].
These initial study questions will certainly also be addressed
with existing PET/MR scanners.
PET-Based Hybrid Techniques
PET/CTCA
Diagnostic Superiority of PET over SPECT
PET has been at the origin of many studies on myocardial
perfusion and myocardial viability [34]. It has many advan-
tages over SPECT, including better spatial resolution and
reliable attenuation correction, as well as a quantitative nature
allowing obtaining absolute myocardial blood flow, and lower
radiation burden [35]. Recent PET scanners are most often
coupled with CT and are therefore hybrid by design (PET/
CT). However, most of the time, the CT is only used for
attenuation correction. The incremental value for predicting
future cardiovascular events and cardiac death due to myocar-
dial blood flow quantitation has also been demonstrated over
SPECT in several studies [36–40]. The scientific basis for
clinical cardiac PET and its use to guide management and
revascularisation has been recently reviewed [41], and is
awaiting confirmation in randomised controlled multicentre
trials.
As with SPECT/CTCA, the addition of CTCA to PET
offers prognostic information, which is not available with
PET/CT alone in the presence of obstructive CAD [42–44]
(Fig. 1) and even nonobstructive CAD [45–47], despite an
incremental prognostic value of CTCA over CCS [48].
A study by Danad et al. evaluated the impact of O-15-water
PET/CTCA imaging on ICA referral and revascularisation in
375 patients [49]. The authors found that in the presence of
equivocal (21 % of the patients) or abnormal CTCA (30 % of
the patients), MPI could guide the decision for ICA referral
and revascularisation.
In a recent head-to-head comparison study, Thomassen
et al. found that CTCA and O-15-water PET had better
diagnostic accuracy than CTCA or PET alone in 44 outpa-
tients scheduled for ICA [50]. Furthermore, the presence of
suboptimal CTA PPV (71 % [95%CI 53–85 %] on a per-
patient basis and 53 % [39–66 %] on a per-vessel basis)
suggested that hybrid PET/CTCA could complement the as-
sessment of coronary stenosis diagnosed by CTA (PET/
CTCA PPV: 100 % [84–100 %] and 85 % [73–97 %],
respectively).
PET/MR
The utility of PET/MR has been speculated before integrated
hybrid prototypes were available [51]. Potential utility in
comparison to stand-alone scanners, is for instance MR-
based attenuation, motion and partial volume correction, im-
proved prognostic stratification of LV function and metabo-
lism in heart failure patients, as well as detailed risk assess-
ment infarction and viability [51, 52•]. Today, there have been
only a limited number of combined studies of nuclear perfu-
sion imaging with MR and more studies are needed to fully
understand the use of multimodality PET/MR techniques in
ischemic cardiomyopathy. Current reviews on the potential of
PET/MR have been published recently [52•, 53, 54•, 55, 56],
but the true value seems to be less clear than in the domain of
oncology [53], without any clear obvious indications or “kill-
er” applications identified yet [52•]. Stress perfusion MRI has
a good sensitivity and specificity for detecting ≥50 % stenosis
in recent metaanalyses [57, 58]. Unlike PET/CT, spatial and
temporal correlations are possible with PET/MR. Also, MR
coronary angiography is currently developing better spatial
resolution and measurement of intracoronary blood flow [59],
which will eventually lead to clinical applications.
Furthermore, left ventricular ejection fraction, end-diastolic
and end-systolic volumes have prognostic implication and
PET-derived regional myocardial glucose consumption gives
complementary information. Finally, MR might be able to
continuously monitor patient movement and eventually obtain
better PET quantitation [52•].
Image interpretation will need a new generation of well-
trained specialists both in PETandMR fields, which represent
an opportunity, but also a challenge for certification [6, 56].
In an initial study with fully integrated PET/MR, Nensa
et al. demonstrated the feasibility of this approach in 20
consecutive patients with myocardial infarct using F-18-
fluorodeoxyglucose (F-18-FDG), with the conclusion that it
may add complementary information in patients with ische-
mic heart disease [60].
Limitations of cardiacMR exist, such as claustrophobia (6–
15 % [61–63]), which is more frequent due to smaller and
longer PET/MR bore [56], impossibility to scan patients with
non-MR-compatible implants (pacemaker, defibrillators, me-
tallic clips) or inject contrast in patients with decreased renal
function (creatinine clearance rate <30 mL/min/1.73 m2).
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Added Value for Prognosis
In a study in 151 consecutive patients with suspected CAD,
Chen et al. found that stress MR and CTCA were highly
concordant (92 % agreement) and negative test results con-
ferred excellent prognosis of event-free survival (MR 97 %,
CTA 99 %) with an average follow-up of 450±115 days [64].
Cost-Effectiveness
So far, combined PET/MR appears to be promising for eval-
uating cardiovascular diseases, but there has not been any
study to determine whether such highly complex and costly
technology is cost-effective, especially taking into account
that the initial investment in a PET/MR scanner is about twice
the cost of a PET/CT scanner.
Right Heart Hybrid Imaging
Right ventricle (RV) is an important determinant of outcome in
different cardiovascular and pulmonary diseases [65]. The use
of multimodality imaging with MR and echography is current
for assessing structure and function, while due to technical
stagnation, nuclear imaging for the RV has become obsolete
nowadays [65]. Unless in the pathologic state of hypertrophied
RV, such as in pulmonary arterial hypertension, RV is difficult
to visualise and might be better seen with PET than SPECT
[65]. It becomes possible to quantify myocardial blood flow in
the right ventricle (Fig. 4) and the feasibility of hybrid imaging
with PET/CTA for the RV remains to be demonstrated.
PET/ICA
A tool that enables going directly from PET imaging into the
catheterisation laboratory without additional radiation burden
would be desirable. We started to develop such a tool able to
reproject the PET myocardial blood flow image onto angio-
graphic projection of rotational X-ray angiograms (Fig. 5).
The potential utility of such an approach needs still to be
evaluated into a pilot study, but would certainly be attractive
for the interventional cardiologist, allowing him to rapidly
visualise the coronary branch responsible for the limited myo-
cardial perfusion, without performing any supplementary
CTCA or injecting additional contrast material, with only a
radiation burden.
Other Non-Nuclear Hybrid Techniques
Hybrid Imaging with Echography
An interesting approach would be the possibility to obtain
three-dimensional information from myocardial contrast
echography to image myocardial perfusion and to perform
fusion imaging with functional SPECT/PET information [66]
or with morphological CT/MR information [67]. The image
fusion of real-time 3-D echography and ICA for guidance
during catheterisation procedures has been demonstrated and
it was found clinically useful not only for mitral clip implan-
tation but also for AF ablation and TAVI aortic valve replace-
ment [68]. So far, such hybrid echographic combinations have
not emerged into clinical applications for ischemic
cardiomyopathy.
Intracoronary Optical Coherence Tomography (OCT)
Intracoronary optical coherence tomography (OCT) is a
catheter-based invasive imaging system that provides accurate
measurements of intraluminal architecture and plaque charac-
terisation [69]. It can be fused with hybrid imaging such as
intravascular ultrasound (IVUS) or CT [70], but it is only
emerging as a hybrid imaging modality, and awaits further
development.
Myocardial CT Perfusion (CTP)/CTCA
Although dynamic CT perfusion (CTP) performed under
adenosine stress and CTCA are not exactly “hybrid” as they
Fig. 4 (a) Three transaxial slices of cardiac Rb-82 myocardial perfusion
imaging in a 55-year women with pulmonary arterial hypertension show-
ing the left ventricle (LV, arrow) and the hypertrophied right ventricle
(RV, arrowhead), usually only faintly visible. (b) Corresponding polar
map quantification of myocardial flow reserve of the left and right
ventricle, with corresponding MFR in each territory and the right
ventricle
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are both from the same CT scanner, they represent a fast and
interesting way of probing the myocardial perfusion and the
coronary arteries.
Added Diagnostic Value
CTP is still in development [71] and comparisons performed
with coronary blood flow and fractional flow ratio (FFR) are
good in animals [72]. Furthermore, diagnostic performance of
detecting functionally significant coronary lesions was im-
proved by a dynamic stress CTP-derived index of myocardial
blood flow over CTCA in 80 symptomatic stable patients with
intermediate pre-test CAD likelihood referred to ICA indicat-
ing potential for use in patient management [73], although an
accompanying editorial outlined several of the study limita-
tions (e.g., lack of rest study hindering distinguishing myo-
cardial scar from ischemia) and outlined the need for a larger
prospective multicentre trial in unselected patients [74].
Two recent studies have shown good results as compared to
nuclear techniques. In a first study, CTP and CTCA could
correctly identify functionally significant ≥50 % stenosis on
SPECT in a large 16-centre study in 381 patients [75]. In the
second study, CT myocardial adenosine stress and rest myo-
cardial perfusion was compared to O-15-water PET myocar-
dial blood flow using a CT-derived method to compute coro-
nary flow reserve (CFR) with a low-dose 320-slice CT in 32
subjects (12 pilot volunteers, 13 validation volunteers and
seven CAD patients) [76]. There was a strong correlation
between PET-derived MBF and CTP-derived MBF (r=0.95,
P<0.0001) and lower CFR in the CAD group than in the
validation group of volunteers (2.3±0.8 vs. 5.2±1.8, P=
0.0011). This established the feasibility of measuring MBF
and CFR by CTP, thus opening new potential applications of
hybrid imaging.
CTCA/ICA
Preprocedural CTCA can be of interest in preparing percuta-
neous intervention (PCI) for chronic total occlusion, which is
present in about 20 % of patient with known or suspected
CAD. In their study, Rolf et al. found that three-dimensional
rendering of the CTCA displayed in the catheter lab during the
Fig. 5 Example of PET/ICA hybrid imaging with our user interface allowing live fusion of PET myocardial blood flow information (in colour) onto
angiographic projection of rotational X-ray angiograms (in black and white) in the catheterization laboratory
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PCI helped to raise the success rate in complex lesions, with
success rate of 88% (22/25 patients) as compared to 63% (16/
25 patients matched) (p=0.03) [77].
Future Perspectives
Radiation Burden and Other Risks
Radiation burden was found initially to be one of the limita-
tions of hybrid imaging with nuclear and CT combined tech-
niques. However, it underwent substantial reduction over the
last decade by at least an order of magnitude and will un-
doubtedly still benefit of further reduction in the future.
Nevertheless, imaging is coupled with risks that are often
not limited to ionizing radiations only; a good review on the
risk of imaging coronary artery disease with ionizing radiation
as well as MR and echography has been recently published,
including risks from stressors, contrast agents, and invasive-
ness, among others [78••]. The review concluded that coro-
nary disease imaging, including ICA, is bound to small, but
detectable acute and long-term risks that are in the same range
of common daily-life activities (e.g. fatal pedestrian accident
risk or about 15 % of fatal motor vehicle accident risk) and
only a fraction of common therapeutic medical intervention
(10–20 % lifetime risk of fatal aspirin bleeding) and only a
minor fraction (2 %) of the risk of lifetime fatal cardiac event
[78••].
Molecular Hybrid Imaging
With the advent of SPECT or PET showing molecular imag-
ing targets involved in the development of vulnerable plaque,
the process of myocardial infarct or the development of heart
failure, such as neoangiogenesis (Fig. 6) or apoptosis, the need
for precise localisation of the observed abnormalities with CT
or MR would be increased [52•, 79, 80].
Cost-Effectiveness
The Study of Myocardial Perfusion and Coronary Anatomy
Imaging Roles in Coronary Artery Disease (SPARC) reg-
ister collected clinical and economical data on 1703 pa-
tients with suspected CAD undergoing CTCA, PET and
SPECT in a standardised fashion with a 2-year clinical
follow-up [81]. This study found that 2-year costs were
lower after using SPECT rather than CTA or PET [82].
They concluded that SPECT was more economically attrac-
tive as compared to PET, whereas CTA was associated
with higher costs and no significant difference in mortality
as compared to SPECT. In an accompanying editorial,
Villines and Min remarked that mean costs were higher
for CTA and PET as compared to SPECT, stemming from
higher rates of ICA and revascularisation [83]. They further
question whether this underscores superior diagnostic per-
formances of CTA and PET as compared to SPECT or just
higher rates of revascularisations. They also salute the step
taken from the SPARC authors in finding new metrics,
which reveals more complexity in the study results analy-
sis. Yet study results are heterogeneous and many centres
did not offer the three modalities rendering head-to-head
comparison impossible. They also note the considerable
technological progress made from the inception of
SPARC in 2006 in terms of CTA (iterative reconstructions,
dual-energy CT, etc.) that outpaced the study. Despites
many limitations, this study should be commended for
asking the right questions (which test, when?) and by
leading the field beyond traditional diagnostic and prognos-
tic performances [83].
Fig. 6 Example of Ga-68-
NODAGA-RGD for imaging
neoangiogenesis in a 72-year
male patient with history of
cardiac infarct 7 years prior to
PET/CT imaging. Selected
transaxial slice through the heart
at 70-min post
radiopharmaceutical injection
showing no abnormal uptake in
the old myocardial infarct
indicating that no active
angiogenesis is taking place
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Conclusion
The utility of hybrid nuclear imaging with PET/CT is well
recognised in oncology, but in cardiology, its utility is less
obvious. Evidence for a clinical utility has accumulated in the
last decade, and a body of proof now exists. Nonetheless, due to
higher costs, low availability and additional radiation exposure,
there are no clear recommendations that have been implemented
into guidelines yet, except a position statement on the use of
hybrid imaging in patients with known or suspected CAD [32•].
Hybrid imaging has a role to play in characterising ischemic
cardiomyopathy as a gatekeeper to the more invasive coronary
angiography in the setting of more personalised medicine. On-
going (EVINCI, SPARC) and future large, multicentric studies
will have to particularly address the cost efficiency and accuracy,
as well as the complementarity of the different hybrid imaging
pathways to help clinicians optimising patient care.
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